Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors

NCT06276309 is registered in ClinicalTrials.gov with Fujian Maternity and Child Health Hospital as lead sponsor.

NCT NCT06276309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06276309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Lead sponsor
Fujian Maternity and Child Health Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2024
Completion date
February 28, 2025
Enrollment
300 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical lesion, china, neuroendocrine neoplasm, women